Table 3.
Characteristics of enrolled subjects at the time of enrollment into study
Parameter | Case group | |
---|---|---|
Age (Y) (Mean ± SD, minimum-maximum) | 55.6 ± 11.9, 43-70 | |
Sex (male: female) | 3:6 | |
Cause of ESRD | ||
Diabetic nephropathy | 2 | |
Hypertensive nephropathy | 3 | |
Poly cystic kidney disease | 1 | |
Recurrent UTI | 1 | |
Glumeronephritis | 0 | |
Unknown | 2 | |
Duration of ESRD (month) (Mean ± SD, minimum-maximum) | 125.4 ± 76, 36-278 | |
Previous HD (yes: no) | 3:6 | |
Duration of previous HD (month) (Mean ± SD, minimum-maximum) | 36.7 ± 66, 0-193 | |
Previous Tx (yes: no) | 3:6 | |
Duration of PD (month) (Mean ± SD, minimum-maximum) | 77.1 ± 41.4, 24-124 | |
Comorbidity | ||
Diabetes (yes: no) | 4:5 | |
Hypertension (yes: no) | 7:2 | |
Transport status | ||
Low | 0 | |
Low average | 0 | |
High average | 6 | |
High | 3 | |
Anuria (yes: no) | 6:3 | |
Ultrafiltration (ml/day) (Mean ± SD, minimum-maximum) | 1216.6 ± 573.4, 300-2000 | |
Weight (kg) (Mean ± SD) | 67.2 ± 12.1 | |
BMI (kg/m2) (Mean ± SD) | 26.9 ± 5.3 | |
SBP (mmHg) (Mean ± SD, minimum-maximum) | 128.8 ± 18.3, 110-170 | |
DBP (mmHg) (Mean ± SD, minimum-maximum) | 80.5 ± 13.3, 65-110 | |
MSCs administration (cell/kg) | 1, 191, 631 ± 132, 327, 941, 176-1, 363, 636 | |
ESRD; End-stage renal disease, UTI; Urinary tract infection, HD; Hemodialysis, Tx; Kidney transplant, PD; Peritoneal dialysis, BMI; Body mass index, SBP; Systolic blood pressure, DBP; Diastolic blood pressure, and MSCs; Mesenchymal stem cells.